A proprietary bionanotechnology platform designed to enhance oral enzyme therapies by protecting enzymes with a nano-shield and binding them to the mucus of the small intestine, improving digestion efficiency and reducing pill burden.

Therapies developed to address digestive enzyme deficiencies by using the Digeia® platform to improve enzyme stability and efficacy in the gastrointestinal tract.